vs
Side-by-side financial comparison of Bausch Health Companies Inc. (BHC) and SONIC AUTOMOTIVE INC (SAH). Click either name above to swap in a different company.
SONIC AUTOMOTIVE INC is the larger business by last-quarter revenue ($3.7B vs $2.8B, roughly 1.3× Bausch Health Companies Inc.). SONIC AUTOMOTIVE INC runs the higher net margin — 1.6% vs -3.7%, a 5.3% gap on every dollar of revenue. On growth, Bausch Health Companies Inc. posted the faster year-over-year revenue change (9.3% vs 1.0%). Over the past eight quarters, Bausch Health Companies Inc.'s revenue compounded faster (14.0% CAGR vs 3.4%).
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic ph...
Sonic Automotive is a Fortune 500 company based in Charlotte, North Carolina, and is the fifth largest automotive retailer in the United States as measured by total revenues. The company was founded by O Bruton Smith and completed its initial public offering on the NYSE in 1997.
BHC vs SAH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $3.7B |
| Net Profit | $-103.0M | $60.8M |
| Gross Margin | — | 16.2% |
| Operating Margin | 17.0% | 3.1% |
| Net Margin | -3.7% | 1.6% |
| Revenue YoY | 9.3% | 1.0% |
| Net Profit YoY | -205.1% | — |
| EPS (diluted) | $-0.30 | $1.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.7B | ||
| Q4 25 | $2.8B | $3.9B | ||
| Q3 25 | $2.7B | $4.0B | ||
| Q2 25 | $2.5B | $3.7B | ||
| Q1 25 | $2.3B | $3.7B | ||
| Q4 24 | $2.6B | $3.9B | ||
| Q3 24 | $2.5B | $3.5B | ||
| Q2 24 | $2.4B | $3.5B |
| Q1 26 | — | $60.8M | ||
| Q4 25 | $-103.0M | $46.9M | ||
| Q3 25 | $179.0M | $46.8M | ||
| Q2 25 | $148.0M | $-45.6M | ||
| Q1 25 | $-58.0M | $70.6M | ||
| Q4 24 | $98.0M | $58.6M | ||
| Q3 24 | $-85.0M | $74.2M | ||
| Q2 24 | $10.0M | $41.2M |
| Q1 26 | — | 16.2% | ||
| Q4 25 | — | 15.5% | ||
| Q3 25 | — | 15.5% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 15.6% |
| Q1 26 | — | 3.1% | ||
| Q4 25 | 17.0% | 3.2% | ||
| Q3 25 | 23.1% | 3.1% | ||
| Q2 25 | 17.5% | -0.6% | ||
| Q1 25 | 12.2% | 4.0% | ||
| Q4 24 | 21.8% | 3.4% | ||
| Q3 24 | 12.7% | 3.3% | ||
| Q2 24 | 16.2% | 3.1% |
| Q1 26 | — | 1.6% | ||
| Q4 25 | -3.7% | 1.2% | ||
| Q3 25 | 6.7% | 1.2% | ||
| Q2 25 | 5.8% | -1.2% | ||
| Q1 25 | -2.6% | 1.9% | ||
| Q4 24 | 3.8% | 1.5% | ||
| Q3 24 | -3.4% | 2.1% | ||
| Q2 24 | 0.4% | 1.2% |
| Q1 26 | — | $1.79 | ||
| Q4 25 | $-0.30 | $1.39 | ||
| Q3 25 | $0.48 | $1.33 | ||
| Q2 25 | $0.40 | $-1.34 | ||
| Q1 25 | $-0.16 | $2.04 | ||
| Q4 24 | $0.24 | $1.67 | ||
| Q3 24 | $-0.23 | $2.13 | ||
| Q2 24 | $0.03 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | — |
| Total DebtLower is stronger | $20.8B | — |
| Stockholders' EquityBook value | $-554.0M | — |
| Total Assets | $26.4B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $6.3M | ||
| Q3 25 | $1.3B | $89.4M | ||
| Q2 25 | $1.7B | $110.4M | ||
| Q1 25 | $1.1B | $64.6M | ||
| Q4 24 | $1.2B | $44.0M | ||
| Q3 24 | $719.0M | $17.6M | ||
| Q2 24 | $595.0M | $67.2M |
| Q1 26 | — | — | ||
| Q4 25 | $20.8B | $1.6B | ||
| Q3 25 | $21.0B | $1.5B | ||
| Q2 25 | $21.7B | $1.5B | ||
| Q1 25 | $21.5B | $1.6B | ||
| Q4 24 | $21.6B | $1.6B | ||
| Q3 24 | $21.5B | $1.7B | ||
| Q2 24 | $21.7B | $1.7B |
| Q1 26 | — | — | ||
| Q4 25 | $-554.0M | $1.1B | ||
| Q3 25 | $-565.0M | $1.1B | ||
| Q2 25 | $-764.0M | $1.0B | ||
| Q1 25 | $-1.2B | $1.1B | ||
| Q4 24 | $-1.3B | $1.1B | ||
| Q3 24 | $-1.2B | $1.0B | ||
| Q2 24 | $-1.2B | $944.7M |
| Q1 26 | — | — | ||
| Q4 25 | $26.4B | $6.0B | ||
| Q3 25 | $26.8B | $6.0B | ||
| Q2 25 | $27.3B | $5.9B | ||
| Q1 25 | $26.4B | $5.9B | ||
| Q4 24 | $26.5B | $5.9B | ||
| Q3 24 | $26.5B | $5.8B | ||
| Q2 24 | $26.5B | $5.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 1.39× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 1.49× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $495.0M | — |
| Free Cash FlowOCF − Capex | $403.0M | — |
| FCF MarginFCF / Revenue | 14.4% | — |
| Capex IntensityCapex / Revenue | 3.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $495.0M | $66.9M | ||
| Q3 25 | $405.0M | $167.9M | ||
| Q2 25 | $289.0M | $136.8M | ||
| Q1 25 | $211.0M | $195.8M | ||
| Q4 24 | $601.0M | $87.7M | ||
| Q3 24 | $405.0M | $87.8M | ||
| Q2 24 | $380.0M | $-136.4M |
| Q1 26 | — | — | ||
| Q4 25 | $403.0M | $-195.6M | ||
| Q3 25 | $314.0M | $134.4M | ||
| Q2 25 | $190.0M | $102.7M | ||
| Q1 25 | $96.0M | $150.8M | ||
| Q4 24 | $495.0M | $-245.5M | ||
| Q3 24 | $334.0M | $34.5M | ||
| Q2 24 | $302.0M | $-185.2M |
| Q1 26 | — | — | ||
| Q4 25 | 14.4% | -5.1% | ||
| Q3 25 | 11.7% | 3.4% | ||
| Q2 25 | 7.5% | 2.8% | ||
| Q1 25 | 4.2% | 4.1% | ||
| Q4 24 | 19.3% | -6.3% | ||
| Q3 24 | 13.3% | 1.0% | ||
| Q2 24 | 12.6% | -5.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.3% | 6.8% | ||
| Q3 25 | 3.4% | 0.8% | ||
| Q2 25 | 3.9% | 0.9% | ||
| Q1 25 | 5.1% | 1.2% | ||
| Q4 24 | 4.1% | 8.6% | ||
| Q3 24 | 2.8% | 1.5% | ||
| Q2 24 | 3.2% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.43× | ||
| Q3 25 | 2.26× | 3.59× | ||
| Q2 25 | 1.95× | — | ||
| Q1 25 | — | 2.77× | ||
| Q4 24 | 6.13× | 1.50× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | 38.00× | -3.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHC
| Bausch Lomb | $1.4B | 50% |
| Salix Segment | $693.0M | 25% |
| International Rx | $306.0M | 11% |
| Diversified Segment | $255.0M | 9% |
| Solta Medical Segment | $137.0M | 5% |
SAH
| Retail new vehicles | $1.6B | 44% |
| Used vehicles | $1.3B | 34% |
| Parts, service and collision repair | $516.6M | 14% |
| Finance, insurance and other, net | $202.4M | 5% |
| Wholesale vehicles | $71.8M | 2% |
| Fleet new vehicles | $20.7M | 1% |
